Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Morgan Stanley 23rd Annual Global

PresentationMichael UlzEquity Analyst All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one the biotech analyst here. It's my pleasure to introduce David Meeker, President and CEO of Rhythm Pharmaceuticals. Before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, pleas ...